| Literature DB >> 24228064 |
Jia-Xu Chen1, Yue-Yun Liu, Shao-Xian Wang, Xiao-Hong Li.
Abstract
Objective. Evaluation of the efficacy of Crest Herbal Crystal Toothpaste in "clearing internal heat." Methods. This was a randomized, double-blind, controlled parallel design clinical test of a product that was already on the market. 72 subjects were randomly assigned to control group (group A with Colgate Herbal Salty Toothpaste) or treatment group (group B with Crest Herbal Crystal Toothpaste) with ratio of 1 : 2. Subjects were instructed to brush with 1g toothpaste for 2 minutes each time, 2 times per day in a 4-aweek test period; measurement with the rating scale on the efficacy of "clearing internal heat" for the herbal toothpaste was done at baseline, 2 weeks, and 4 weeks of toothpaste usage. Results. The rating scale on efficacy of "clearing internal heat" for the herbal toothpaste reveals that the primitive points of 72-case intention-to-treat (ITT) analysis and 67-case per-protocol (PP) analysis for subjects in group A and subjects in group B were found to be reduced progressively with statistical significance (P < 0.05). The overall effective rates for group A and group B were, respectively, 62.50%, 56.25% (ITT) and 62.50%, 60.64% (PP). The statistical results indicated that the symptoms of fire-heat for both groups of subjects have been improved after application of toothpaste. Conclusion. The efficacy of Crest Herbal Crystal Toothpaste in "clearing internal heat" was confirmed by the trial as compared to Colgate Herbal Salty Toothpaste. And its efficacy was objectively evaluated by the rating scale on efficacy of "clearing internal heat."Entities:
Year: 2013 PMID: 24228064 PMCID: PMC3817745 DOI: 10.1155/2013/807801
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Box 1Description for package of toothpaste used in the trial.
Figure 1Participant flow through recruitment to trial completion.
Comparison of demographic data between the two groups (mean value ± standard deviation).
| Group | Sex (male/female) | Age ( | Grade of symptoms ( |
|---|---|---|---|
| Group A (24 subjects) | 7/17 | 28.42 ± 7.52 | 28.33 ± 6.79 |
| Group B (48 subjects) | 9/39 | 27.88 ± 6.99 | 26.25 ± 4.88 |
|
| 0.3162 ( | 0.6789 ( | 0.2337 ( |
Comparison of original accumulated points among 72 subjects between the two groups before and after treatment (mean value ± standard deviation) (intention-to-treat (ITT) analysis).
| Group | Baseline | Week 2 | Week 4 |
|---|---|---|---|
| Group A (24 subjects) | 28.33 ± 6.79 | 21.75±6.04* | 19.54±6.19* |
| Group B (48 subjects) | 26.25 ± 4.88 | 20.02±5.72* | 17.73±5.48* |
Compare with the result before treatment in the group, *P < 0.05.
Comparison of original accumulated points among 67 subjects between the two groups before and after treatment (mean value ± standard deviation) (per-protocol (PP) analysis).
| Group | Baseline | Week 2 | Week 4 |
|---|---|---|---|
| Group A (24 subjects) | 28.33 ± 6.79 | 21.75±6.04* | 19.54±6.19* |
| Group B (43 subjects) | 26.34 ± 4.82 | 19.95±5.50* | 17.40±5.22* |
Compare with the result before treatment in the group, *P < 0.05.
Effective rate of full analysis set for 72 subjects in the two groups after treatment (%, ITT).
| Q1 | Q2 |
|
|
|
|
|
|
|
|
| (total) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group A (24 subjects) | 26% | 31% | 26% | 30% | 41% | 32% | 40% | 37% | 19% | 30% | 23% | 31% |
| Group B (48 subjects) | 29% | 36% | 41% | 33% | 39% | 35% | 33% | 38% | 23% | 12% | 22% | 32% |
Mean = − 0.0058; SD = 0.078; t = −0.2597; P > 0.05.
Effective rate of PP set for 67 subjects in the two groups after treatment (%, PP).
|
|
|
|
|
|
|
|
|
|
|
| (total) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group A (24 subjects) | 26% | 31% | 26% | 30% | 41% | 32% | 40% | 37% | 19% | 30% | 23% | 31% |
| Group B (43 subjects) | 31% | 38% | 43% | 35% | 43% | 36% | 33% | 39% | 24% | 15% | 22% | 34% |
Mean = − 0.0225; SD = 0.077; t = −1.006; P > 0.05.
Evaluating the overall effective rate of both groups with the rating scale (the 3rd edition) [4] after treatment (number of cases and %).
| Dataset | Group | Cure | Markedly effective | Effective | Ineffective | |
|---|---|---|---|---|---|---|
| FA set | Group A (24 subjects) | 0 (0) | 0 (0) | 15 (62.50) | 9 (37.50) |
|
| (ITT) | Group B (48 subjects) | 0 (0) | 0 (0) | 27 (56.25) | 21 (43.75) |
|
| PP set | Group A (24 subjects) | 0 (0) | 0 (0) | 15 (62.50) | 9 (37.50) |
|
| (PP) | Group B (43 subjects) | 0 (0) | 0 (0) | 26 (60.64) | 17 (39.53) |
|
(Full analysis) FA set P = 0.6446, PP set P = 0.6446.
| 1 | 2 | 3 | 4 | 5 | |
| Never | Occasionally | Often | Very often | Always | |
| How often was it, that you (your) | 1 | 2 | 3 | 4 | 5 |
| (1) feel dryness of throat; | □ | □ | □ | □ | □ |
| (2) feel thirsty and want to drink especially cold water; | □ | □ | □ | □ | □ |
| (3) feel bitter taste in mouth; | □ | □ | □ | □ | □ |
| (4) suffered from oral malodor (halitosis); | □ | □ | □ | □ | □ |
| (5) suffered from oral ulcer on mucosa or tongue; | □ | □ | □ | □ | □ |
| (6) suffered from swelling and aching of gums; | □ | □ | □ | □ | □ |
| (7) suffered from bleeding gums; | □ | □ | □ | □ | □ |
| (8) suffered from toothache; | □ | □ | □ | □ | □ |
| (9) suffered from lightly swelling, but no red or aching of gums; | □ | □ | □ | □ | □ |
| (10) suffered from loose teeth and inability to chew; | □ | □ | □ | □ | □ |
| (11) suffered from dry teeth (sticky feeling between the teeth and upper and lower lips). | □ | □ | □ | □ | □ |